Overview

Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain

Status:
Recruiting
Trial end date:
2025-04-05
Target enrollment:
Participant gender:
Summary
The goal of this pilot study is to describe and compare Ultrasound-Guided Erector Spinae Plane (ESP) Blocks using Exparel® (bupivacaine liposome injectable suspension) to Marcaine® (bupivacaine hydrochloride) for pain management and outcomes after cardiac surgeries.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborator:
Pacira Pharmaceuticals, Inc
Treatments:
Bupivacaine